Skip to main navigation
Skip to search
Skip to main content
Queen's University Belfast Home
Help & FAQ
Home
Profiles
Research units
Research output
Projects
Impacts
Datasets
Activities
Prizes
Press/Media
Student theses
Equipment
Search by expertise, name or affiliation
Biological and clinical implications of BIRC3 mutations in chronic lymphocytic leukemia
Davide Rossi
School of Medicine, Dentistry and Biomedical Sciences
Patrick G Johnston Centre for Cancer Research
Research output
:
Contribution to journal
›
Article
›
peer-review
71
Citations (Scopus)
295
Downloads (Pure)
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'Biological and clinical implications of BIRC3 mutations in chronic lymphocytic leukemia'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Medicine and Dentistry
B-Cell Chronic Lymphocytic Leukemia
100%
Fludarabine
71%
Cyclophosphamide
42%
Rituximab
42%
Patient
28%
Gene
28%
Progression Free Survival
28%
Analysis
14%
Hazard Ratio
14%
Association
14%
Combination Therapy
14%
Inpatient
14%
Cell Line
14%
Multivariate Analysis
14%
Leukemia Cell
14%
Western Blot
14%
Next Generation Sequencing
14%
Univariate Analysis
14%
Chemoimmunotherapy
14%
IGHV@
14%
Biochemistry, Genetics and Molecular Biology
Mutation
100%
Fludarabine
50%
Cyclophosphamide
30%
Rituximab
30%
Progression Free Survival
20%
Mutated Genes
20%
Sample
10%
Association
10%
Multivariate Analysis
10%
IGHV@
10%